(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -28.42%2.05B | -56.13%763.74M | 20.20%2.86B | 50.45%1.74B | 28.51%2.38B | 83.04%1.16B | 11.85%1.85B | 6.35%632.14M | -5.28%1.66B | -31.37%594.38M |
Operating income | -28.42%2.05B | -56.13%763.74M | 20.20%2.86B | 50.45%1.74B | 28.51%2.38B | 83.04%1.16B | 11.85%1.85B | 6.35%632.14M | -5.28%1.66B | -31.37%594.38M |
Operating expenses | 16.70%-1.35B | 58.13%-390.35M | -10.51%-1.63B | -22.84%-932.34M | -3.88%-1.47B | -30.79%-758.97M | -5.23%-1.42B | -9.91%-580.3M | 6.48%-1.35B | 24.60%-527.96M |
Gross profit | -43.83%695.04M | -53.81%373.4M | 35.87%1.24B | 103.07%808.45M | 108.32%910.7M | 667.88%398.12M | 40.48%437.16M | -21.94%51.85M | 0.24%311.19M | -59.95%66.42M |
Selling expenses | -43.19%-10.1M | 46.17%-3.91M | 54.45%-7.05M | 70.94%-7.26M | 57.68%-15.48M | -52.04%-24.98M | 23.12%-36.58M | 9.62%-16.43M | -48.88%-47.58M | 7.10%-18.18M |
Administrative expenses | 9.96%-202.26M | -0.22%-70.29M | -54.29%-224.63M | -14.49%-70.14M | -20.32%-145.59M | -19.18%-61.26M | 0.94%-121M | 10.35%-51.4M | -19.46%-122.15M | -15.89%-57.34M |
Research and development expenses | 38.36%-58M | 80.11%-12.53M | -36.19%-94.09M | ---62.99M | ---69.09M | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | ---- | -128.37%-342.05K | --449.89K | -171.80%-149.78K | ---- | 153.03%208.6K | --38.5K | -4,119.44%-393.36K | ---- |
Revaluation surplus | -267.91%-64.09M | ---20.49M | --38.17M | ---- | ---- | ---- | ---655.36K | ---- | ---- | ---- |
-Changes in the fair value of other assets | -267.91%-64.09M | ---20.49M | --38.17M | ---- | ---- | ---- | ---655.36K | ---- | ---- | ---- |
Impairment and provision | 61.59%-38.14M | 103.46%138.32K | -3,461.39%-99.3M | -204.85%-4M | 102.14%2.95M | --3.81M | -9,082.35%-138.3M | ---- | 3.20%-1.51M | -140.69%-107.95K |
-Other impairment is provision | 61.59%-38.14M | 103.46%138.32K | -3,461.39%-99.3M | -204.85%-4M | 102.14%2.95M | --3.81M | -9,082.35%-138.3M | ---- | 3.20%-1.51M | -140.69%-107.95K |
Special items of operating profit | -122.25%-23.66M | -119.10%-12.63M | 2,450.44%106.34M | 231.42%66.09M | -14.39%4.17M | 279.53%19.94M | -80.92%4.87M | 156.56%5.25M | 9.11%25.53M | 922.01%2.05M |
Operating profit | -71.40%255.72M | -66.50%233.34M | 40.31%894.14M | 123.83%696.56M | 477.40%637.28M | 1,355.25%311.2M | -16.32%110.37M | -13.23%-24.79M | -17.23%131.9M | -127.76%-21.89M |
Financing cost | 0.71%-49.66M | 15.39%-22.06M | 21.80%-50.02M | 30.82%-26.07M | 34.11%-63.96M | 24.82%-37.69M | -1.56%-97.07M | -3.31%-50.13M | 28.40%-95.58M | 27.56%-48.52M |
Special items of earning before tax | 136.56%3.9M | -199.20%-196.51K | -240.01%-10.66M | 127.78%198.09K | -101.98%-3.14M | 76.07%-713.2K | 7,239.89%158.23M | -808.07%-2.98M | 98.63%-2.22M | -361.03%-328.16K |
Earning before tax | -74.81%209.95M | -68.53%211.09M | 46.17%833.46M | 145.86%670.69M | 232.42%570.18M | 450.20%272.8M | 402.93%171.53M | -10.11%-77.9M | 125.16%34.11M | -688.29%-70.74M |
Tax | 47.23%-47.61M | 33.15%-40.78M | -61.34%-90.23M | -38.51%-61.01M | -831.58%-55.92M | -387.86%-44.05M | 182.53%7.64M | 55.53%15.3M | -759.19%-9.26M | 406.22%9.84M |
After-tax profit from continuing operations | -78.16%162.34M | -72.07%170.3M | 44.52%743.24M | 166.53%609.68M | 187.02%514.26M | 465.44%228.75M | 621.21%179.17M | -2.78%-62.6M | 118.52%24.84M | -791.12%-60.91M |
Earning after tax | -78.16%162.34M | -72.07%170.3M | 44.52%743.24M | 166.53%609.68M | 187.02%514.26M | 465.44%228.75M | 621.21%179.17M | -2.78%-62.6M | 118.52%24.84M | -791.12%-60.91M |
Minority profit | 77.36%-321.07K | -199.96%-100.43K | -7.14%-1.42M | 104.72%100.48K | -104.84%-1.32M | -647.23%-2.13M | 1,160.38%27.33M | 83.55%-285.13K | 96.78%-2.58M | -2,232.52%-1.73M |
Profit attributable to shareholders | -78.16%162.66M | -72.05%170.4M | 44.43%744.65M | 164.02%609.58M | 239.56%515.59M | 470.53%230.88M | 453.74%151.84M | -5.30%-62.31M | 150.60%27.42M | -777.71%-59.17M |
Basic earnings per share | -79.41%0.07 | -72.10%0.077 | 47.83%0.34 | 165.38%0.276 | 233.33%0.23 | 471.43%0.104 | 475.00%0.069 | -3.70%-0.028 | 148.00%0.012 | -775.00%-0.027 |
Diluted earnings per share | -79.41%0.07 | -72.10%0.077 | 47.83%0.34 | 165.38%0.276 | 233.33%0.23 | 471.43%0.104 | 475.00%0.069 | -3.70%-0.028 | 148.00%0.012 | -775.00%-0.027 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data